Journal profile · MEDICINE, RESEARCH & EXPERIMENTAL
Cold Spring Harbor Molecular Case Studies
ISSN 2373-2873 · Cold Spring Harbor Laboratory Press
Cold Spring Harbor Molecular Case Studies: fully open access; review about 42 days (submission to first decision, publisher); 0 articles in 2025; indexed in Scopus; flagged on an early-warning list or for an indexing change: check before submitting.
Scope
Aims, scope and focus
Cold Spring Harbor Molecular Case Studies is published by Cold Spring Harbor Laboratory Press. By OpenAlex counts of its recent articles, its largest topics are Genomics and Rare Diseases, Cancer Genomics and Diagnostics and Genomic variations and chromosomal abnormalities, together about 41.3% of its articles. Its main subfields are Genetics. (generated from OpenAlex topic counts and CAS ranking data)
An open-access, peer-reviewed, international journal in the field of precision medicine. Articles in the journal present genomic and molecular analyses of individuals or cohorts alongside their clinical presentations and phenotypic information.
From the journal's Aims & Scope
Research area (LetPub): MEDICINE, RESEARCH & EXPERIMENTAL
Editor-in-chief Elaine MardisPublisher website
Main research topics OpenAlex counts of recent articles; shares are approximate
- Genomics and Rare DiseasesBiochemistry, Genetics and Molecular Biology24.5%
- Cancer Genomics and DiagnosticsBiochemistry, Genetics and Molecular Biology10.2%
- Genomic variations and chromosomal abnormalitiesBiochemistry, Genetics and Molecular Biology6.6%
- Genetics and Neurodevelopmental DisordersBiochemistry, Genetics and Molecular Biology5.3%
- Metabolism and Genetic DisordersBiochemistry, Genetics and Molecular Biology5.1%
- Chromatin Remodeling and CancerBiochemistry, Genetics and Molecular Biology5%
- BRCA gene mutations in cancerBiochemistry, Genetics and Molecular Biology3.7%
- Sarcoma Diagnosis and TreatmentMedicine3.4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
CiteScore quartiles (Scopus, June 2026 release)
| Subject | Quartile | Rank | Percentile |
|---|---|---|---|
| Genetics (clinical) | Q3 | 56/100 | 44th |
| Genetics | Q3 | 203/348 | 41st |
| Biochemistry | Q3 | 275/441 | 37th |
| Molecular Medicine | Q3 | 123/177 | 30th |
Scopus ranks journals by CiteScore within each subject: the 75th percentile and above is Q1, then a quartile every 25 points. A different system from the CAS zones.LetPub
Database indexing
ScopusLetPub
Early warning / risk: Marked as ceased in ESCI on 17 September 2024. CAS Early Warning Journal List: not listed in any of 6 editions.LetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore 2026-06
- 4LetPub ·
- SJR 2026-06
- 0.81LetPub ·
- SNIP 2026-06
- 0.67LetPub ·
- h-index
- 39OpenAlex ·
- i10-index
- 263OpenAlex ·
- 2-year mean citedness
- 0OpenAlex ·
- Share of gold OA articles
- 90.97%LetPub ·
Volume
- Articles per year
- 38LetPub ·
Articles by year OpenAlex count · 463 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 0 | 0 | 674 |
| 2025 | 0 | 0 | 1,000 |
| 2024 | 0 | 0 | 1,110 |
| 2023 | 38 | 38 | 1,040 |
| 2022 | 44 | 44 | 1,122 |
| 2021 | 64 | 64 | 1,082 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Submission to first decision
- 42 daysPublisher website ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessOpenAlex
Every article is open access; authors usually pay an article processing charge (APC).
No source has fee information yet; check the journal's website.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Cold Spring Harbor Laboratory Press
- ISSN
- 2373-2873
- Official links
- Journal homepage ↗OpenAlex
FAQ
Frequently asked questions about Cold Spring Harbor Molecular Case Studies
How long does peer review take at Cold Spring Harbor Molecular Case Studies?
The publisher reports about 42 days (submission to first decision); first decisions include desk rejections. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Cold Spring Harbor Molecular Case Studies?
According to LetPub and DOAJ records, Cold Spring Harbor Molecular Case Studies is indexed in Scopus.
Is Cold Spring Harbor Molecular Case Studies open access, and what is the APC?
Cold Spring Harbor Molecular Case Studies is a fully open-access journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .